Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study

BACKGROUND: This study aimed to investigate whether the addition of candesartan to the standard care regimen improved the outcome in patients with coronavirus 2019 (COVID-19). METHODS: A prospective non-randomized open-label study was undertaken from May to August 2020 on 75 subjects (aged 18–70 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lukito, Antonia Anna, Widysanto, Allen, Lemuel, Theo Audi Yanto, Prasetya, Ignatius Bima, Massie, Billy, Yuniarti, Mira, Lumbuun, Nicolaski, Pranata, Raymond, Meidy, Cindy, Wahjoepramono, Eka Julianta, Yusuf, Irawan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142270/
https://www.ncbi.nlm.nih.gov/pubmed/34038766
http://dx.doi.org/10.1016/j.ijid.2021.05.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142270/
https://www.ncbi.nlm.nih.gov/pubmed/34038766
http://dx.doi.org/10.1016/j.ijid.2021.05.019

Ejemplares similares